VICEBIO LTD

HQ - London

Summary

Vicebio is a clinical-stage biopharmaceutical company developing transformative multi-pathogen vaccines for respiratory viral infections.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 1.19 B

Avg. Deal Size£ 1.19 B

Market Context

Senior Management